knowledge -WSS

knowledge

author：hotspot 2025-10-01 22:49:17 - browse：5

Researchers say they’ve been able to measure recovery from treatment-resistant depression through brain scans — a crucial step toward quantifying the impact of therapies on a condition whose progress is notoriously difficult to measure objectively. And that’s thanks to generative AI, they say.

In a small study published Wednesday — just 10 people with severe, treatment-resistant depression receiving deep brain stimulation therapy — researchers used the electrodes to record brain activity and later fed the scans into a homegrown artificial intelligence system that analyzed them for patterns. They found that it was possible to track patients’ recovery through changes in brain cells’ electrical activity.

Finding so-called biomarkers, or objective measurements reflecting depression, could help diagnose depression, track its progression, predict a relapse, and better tailor therapies to individual patients. But finding those metrics has been difficult, partly because depression’s biological impact isn’t well understood.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： FDA panel signals lack of confidence in Amgen cancer drug data

WSS

Analysis of telehealth claims data suggest service duplication

Adults seen as increasingly susceptible to measles

Chan Zuckerberg Biohub Chicago to focus on inflammation

Wildfire pollution widens asthma inequities on Long Island

When women are denied an abortion, their children fare worse than peers

Physician groups backed by private equity giant lobby on mergers

entertainment

knowledge

knowledge

Psychedelics group wrestles with new pharma identity

5 important ways Henrietta Lacks changed medical science

State Dept. review finds Biden bears some blame for Afghanistan failures

Sage hopes for a blockbuster in antidepressant now before FDA

New air purifier tech could be key to improving indoor air quality

Pence says 'crackpot lawyers' told Trump what he wanted to hear

Cancer drug shortages should be causing more outrage

What to expect as Trump is arraigned on his Jan 6. indictment

Medical records are filled with copy

FDA rejects Alnylam's heart disease treatment over insufficient data

hotspot

Vertex non

FDA authorizes Novavax’s updated Covid

Stroke deaths set to near 10 million globally by 2050

VC firm General Catalyst wants to buy a health system

Breakthrough Alzheimer’s drugs are inaccessible in rural states

FDA rejects Alnylam's heart disease treatment over insufficient data

hotspot

leisure time

explore

leisure time